Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1,367.00
-80.00
(-5.53%)
At close: April 4 at 8:31:35 AM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 12 | 12 |
| Avg. Estimate | 3.9B | 3.24B | 16.25B | 16.94B |
| Low Estimate | 3.63B | 3.04B | 13.76B | 14.18B |
| High Estimate | 4.08B | 3.39B | 18.49B | 19.53B |
| Year Ago Sales | 3.64B | 3.01B | 13.19B | 16.25B |
| Sales Growth (year/est) | 7.05% | 7.76% | 23.25% | 4.27% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SRE.MX | -- | -- | -- | -- |
| S&P 500 | 6.57% | 6.54% | 9.73% | 14.28% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 3/26/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 3/20/2025 |
| Maintains | BMO Capital: Outperform to Outperform | 3/4/2025 |
| Downgrade | Jefferies: Buy to Hold | 3/3/2025 |
| Downgrade | Barclays: Overweight to Equal-Weight | 2/27/2025 |
| Downgrade | Goldman Sachs: Buy to Neutral | 2/26/2025 |